Related Experiment Videos
Gene therapy for Parkinson's disease: current status and future potential
1Departamento de Fisiología, Biofísica y Neurociencias, Centro de Investigación y de Estudios Avanzados del IPN, Distrito Federal, Mexico. jsegovia@fisio.cinvestav.mx
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|June 27, 2002
Summary
Gene therapy offers promising Parkinson's disease treatments by replacing lost dopamine or protecting neurons. Strategies include engineering cells for dopamine production or generating new dopaminergic neurons for a potential cure.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Parkinson's disease (PD) is characterized by dopamine deficiency in the caudate-putamen.
- The neuropathology of PD involves the death of nigral dopamine-producing neurons in a circumscribed brain region.
Purpose of the Study:
- To explore gene therapy strategies for treating Parkinson's disease.
- To evaluate the potential of different gene therapy approaches for neuroprotection and neuronal replacement.
Main Methods:
- Engineering cells to produce levodopa or dopamine to restore neurotransmission.
- Transferring genes encoding neurotrophic factors for cellular protection.
- Generating cells with a dopaminergic phenotype for neuronal replacement.
Main Results:
- Behavioral recovery observed in animal models using cell-based dopamine replacement.
- Promising results reported for neurotrophic factor gene therapy.
- Development of strategies for dopaminergic neuron replacement shows potential for a cure.
Conclusions:
- Gene therapy is a promising avenue for Parkinson's disease treatment.
- Multiple gene therapy strategies are being investigated, including cell replacement and neuroprotection.
- Further research in gene therapy holds significant potential for treating neurodegenerative disorders like PD.